Hanmi Pharm. Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 989.73 million compared to KRW 314.98 million a year ago. Net income was KRW 18,422.39 million compared to KRW 7,112.01 million a year ago. Basic earnings per share from continuing operations was KRW 1,479.4118 compared to KRW 570.5882 a year ago. Basic earnings per share was KRW 1,479.4118 compared to KRW 570.5882 a year ago.
For the six months, sales was KRW 1,837.73 million compared to KRW 498.88 million a year ago. Net income was KRW 37,937.39 million compared to KRW 26,155.75 million a year ago. Basic earnings per share from continuing operations was KRW 3,046.0784 compared to KRW 2,097.0588 a year ago. Basic earnings per share was KRW 3,046.0784 compared to KRW 2,097.0588 a year ago.